Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil SR in Newly Diagnosed Type 1 Diabetes Mellitus
NCT04545151Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Feb 2021
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of verapamil in type 1 diabetes mellitus (T1D), sponsored by Medical University of Graz. Started Feb 2021; status: completed.
02
Drugs
verapamil
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04545151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545151.